Panel Discussion | Transcatheter Mitral Valve Therapies | Challenges and Opportunities

Monday, March 10, 2025

4:32 PM – 5:00 PM ET

Panel Moderator(s)

Anita W. Asgar, MD, FACC

Interventional Cardiologist
Northwestern Medicine
Outremont, Quebec, Canada

Disclosure information not submitted.
Steven F. Bolling, MD

Professor of Cardiac Surgery
University of Michigan Hospital
Ann Arbor, Michigan, United States

Disclosure information not submitted.

Panel Discussant(s)

Karim Al-Azizi, MD, FACC, FSCAI, FESC

Medical Director, Cardiac Catheterization Laboratories
The Heart Hospital, Baylor Scott & White Health Baylor Scott & White
Frisco, Texas, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); shockwave: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Vinayak Bapat, FRCS(CTh)

Consultant
Abbott Northwestern Hospital & Minneapolis Heart Foundation
Minneapolis, Minnesota, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)
Jeff W. Chambers, MD, FSCAI, FACC

Director of the percutaneous Coronary Interventions
Metropolitian Heart and Vascular Institute
Minneapolis, Minnesota, United States

Disclosure(s): No financial relationships to disclose
Mayra E. Guerrero, MD, FACC, FSCAI

Professor of Medicine
Mayo Clinic Hospital
Rochester, Minnesota, United States

Disclosure information not submitted.
Scott Lim, MD

Professor of Medicine
University of British Columbia
Charlottesville, Virginia, United States

Disclosure information not submitted.
Michael J. Mack, MD

Chair, Cardiovascular Servivce Line
Heart Hospital Baylor Plano
Plano, Texas, United States

Disclosure information not submitted.
Lars Sondergaard, MD

Chief Medical Officer
Abbott Structural Heart
Santa Clara, California, United States

Disclosure(s): Abbott Structural Heart, Medtronic, Boston Scientific: Employee (Ongoing)
Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)
Dee Dee Wang, MD

co-Deputy Editor
JACC Case Reports, Michigan, United States

Disclosure information not submitted.

Disclosure(s):

Karim Al-Azizi, MD, FACC, FSCAI, FESC: Abbott Labs: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); shockwave: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Vinayak Bapat, FRCS(CTh): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)

Jeff W. Chambers, MD, FSCAI, FACC: No financial relationships to disclose

Lars Sondergaard, MD: Abbott Structural Heart, Medtronic, Boston Scientific: Employee (Ongoing)

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)